ATG7 Protein is a protein involved in key cellular signaling pathways relevant to neurodegenerative diseases. This page provides comprehensive information about its structure, normal biological function, and role in disease pathogenesis.
ATG7 Protein participates in critical cellular processes that, when dysregulated, contribute to neurodegeneration. Understanding this protein's function is essential for developing therapeutic interventions for Alzheimer's disease, Parkinson's disease, and related conditions.
| ATG7 Protein | |
|---|---|
| Protein Name | ATG7 |
| Gene | [ATG7](/genes/atg7) |
| UniProt ID | O95352 |
| PDB Structure | 3T7D, 5JGC, 6L8Q |
| Molecular Weight | 78 kDa |
| Subcellular Localization | Cytoplasm (autophagosome formation sites) |
| Protein Family | ATG family (E1-like activating enzyme) |
ATG7 is an E1-like activating enzyme with an N-terminal domain that forms a thioester bond with the C-terminal glycine of ATG8 (LC3) and ATG12 proteins, and a C-terminal domain that binds ATP. The protein undergoes conformational changes during the activation process.
ATG7 is an E1-like activating enzyme essential for autophagy. It activates ATG8 family proteins (LC3, GABARAP) and ATG12 through thioester bond formation, enabling their conjugation to phosphatidylethanolamine or ATG5, respectively. These ubiquitin-like conjugation systems are required for autophagosome formation. ATG7 also has non-autophagic functions in cell cycle regulation and tumor suppression.
ATG7 is critical for neuronal survival. Neuron-specific ATG7 deletion causes neurodegeneration in mice, demonstrating its essential role in the nervous system. In AD, autophagy is impaired and ATG7 expression is altered. In PD, ATG7-mediated mitophagy is important for mitochondrial quality control. ATG7 polymorphisms are associated with neurodegenerative disease risk.
ATG7 activators are being explored to enhance autophagy in neurodegenerative diseases. Small molecules that promote ATG7 function or expression could enhance clearance of pathological proteins. Gene therapy approaches to increase ATG7 expression are also being investigated.